Federated AI for Hospital Infection Surveillance

Abstract

Hospital-acquired infections (HAIs) represent a significant challenge to patient safety and healthcare resource utilization globally. Traditional surveillance methods are limited by fragmented data and privacy concerns. Federated artificial intelligence (AI) offers a novel approach to infection surveillance, enabling collaborative model development without the need for data centralization. This review synthesizes current evidence, highlights the scientific mechanisms, and provides clinically relevant insights into the role of federated AI in hospital infection surveillance, with emphasis on epidemiology, pathophysiology, risk factors, clinical features, diagnosis, management strategies, and emerging technologies. Practical implications and guideline recommendations are discussed to inform the integration of federated AI into clinical practice.

Introduction

Hospital-acquired infections pose a persistent threat to modern healthcare systems, contributing to increased morbidity, mortality, and healthcare costs. Effective infection surveillance is critical for early detection, outbreak containment, and quality improvement initiatives. Conventional data aggregation approaches are hindered by patient privacy regulations, siloed data environments, and logistical barriers to large-scale data sharing. Federated AI, which enables decentralized data analysis while preserving data sovereignty, has emerged as a transformative solution for enhancing surveillance without compromising confidentiality. This article critically examines the scientific, clinical, and operational aspects of federated AI in hospital infection surveillance, drawing on recent literature and expert consensus.

Epidemiology / Disease Burden

Hospital-acquired infections affect millions of patients annually worldwide, with the World Health Organization estimating that up to 7% of hospitalized patients in developed countries and 10% in developing countries acquire at least one HAI. Common pathogens include methicillin-resistant Staphylococcus aureus (MRSA), Clostridioides difficile, and multidrug-resistant Gram-negative bacteria. The burden is exacerbated by antimicrobial resistance, prolonged hospital stays, and increased risk of mortality. Surveillance data, when accurate and timely, are essential for tracking trends, identifying outbreaks, and deploying targeted interventions. However, epidemiological assessments are often hampered by incomplete data capture and reporting inconsistencies, underscoring the need for innovative surveillance methodologies.

Pathophysiology

The pathogenesis of HAIs involves a complex interplay between host vulnerability, pathogen virulence, and environmental factors within healthcare settings. Disruption of skin and mucosal barriers, immunosuppression, invasive procedures, and exposure to contaminated surfaces or equipment facilitate pathogen transmission. Biofilm formation on medical devices further complicates eradication efforts. Understanding these mechanisms is crucial for developing predictive models that identify high-risk scenarios and guide infection prevention strategies. Federated AI algorithms can integrate multi-modal data—clinical, microbiological, and environmental—to elucidate pathophysiological patterns associated with infection onset and propagation.

Risk Factors

Risk factors for HAIs are multifactorial, encompassing patient characteristics (advanced age, comorbidities, immunosuppression), procedural exposures (catheterization, mechanical ventilation, surgical interventions), and organizational factors (staffing ratios, hand hygiene compliance, antimicrobial stewardship practices). Data on risk stratification are often fragmented across institutions, limiting the ability to generalize findings and develop robust predictive models. Federated AI addresses this by enabling cross-institutional learning, where algorithms are trained on heterogeneous datasets without centralizing sensitive patient information. This approach enhances the generalizability of risk prediction tools and supports precision prevention strategies tailored to local epidemiology.

Clinical Features

Clinical manifestations of HAIs vary by pathogen and site of infection but commonly include fever, leukocytosis, localized pain or inflammation, and signs of sepsis. Device-associated infections may present insidiously, with subtle changes in vital signs or laboratory parameters preceding overt clinical deterioration. Early detection relies on vigilant monitoring and interpretation of clinical, laboratory, and radiological data. Federated AI models can synthesize these data streams in real-time across multiple sites, facilitating early recognition of infection clusters and atypical presentations, thereby enabling prompt intervention and containment.

Diagnosis

Accurate diagnosis of HAIs depends on a combination of clinical assessment, laboratory testing (e.g., cultures, molecular diagnostics), and epidemiological investigation. Diagnostic delays or inaccuracies may result from non-specific symptoms, prior antimicrobial exposure, or limited access to advanced diagnostics. Federated AI frameworks can harmonize diagnostic criteria and leverage distributed data to refine case definitions, reduce false positives/negatives, and support automated alert systems. Recent studies have demonstrated that federated learning can improve diagnostic model performance while preserving data privacy, especially in multi-center settings with diverse patient populations and laboratory practices.

Treatment & Management

Management of HAIs involves prompt initiation of appropriate antimicrobial therapy, source control measures, and adherence to infection prevention protocols. Individualized treatment decisions are informed by local antibiograms, patient-specific factors, and pathogen characteristics. Federated AI can facilitate adaptive clinical decision support systems that incorporate evolving resistance patterns and institutional practices. By continuously learning from distributed real-world data, such systems can recommend optimal empiric therapies, monitor outcomes, and identify gaps in care. Furthermore, federated approaches enable benchmarking and quality improvement initiatives without compromising patient confidentiality.

Recent Advances / Emerging Therapies

The application of federated AI to infection surveillance has accelerated in recent years. Notable advances include the development of privacy-preserving predictive models for infection risk, outbreak detection algorithms, and federated transfer learning to adapt models across healthcare environments. Emerging therapies, such as phage therapy and novel antimicrobials, are increasingly being studied using federated clinical trial designs to overcome recruitment and data-sharing barriers. Integration of wearable sensor data and environmental monitoring into federated learning frameworks holds promise for proactive infection prevention and personalized interventions.

Guideline Recommendations

Leading health authorities, including the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), advocate for the adoption of advanced digital surveillance tools to complement traditional infection control strategies. While specific guidelines on federated AI are evolving, consensus supports the use of privacy-enhancing technologies and collaborative analytics to enhance HAI surveillance. Institutions are encouraged to invest in secure federated infrastructure, multidisciplinary governance, and continuous model validation to ensure clinical utility and regulatory compliance. Ongoing research and knowledge sharing are essential to refine best practices and maximize the benefits of federated AI in infection surveillance.

Conclusion

Federated AI represents a paradigm shift in hospital infection surveillance, offering a scalable, privacy-preserving solution to longstanding challenges in data sharing and collaborative analytics. By harnessing distributed data sources, federated approaches improve the accuracy, timeliness, and generalizability of infection detection and risk prediction models. Clinically, this translates to earlier identification of outbreaks, optimized resource allocation, and enhanced patient safety. As the field matures, continued investment in infrastructure, interdisciplinary collaboration, and guideline development will be critical to realizing the full potential of federated AI in combating hospital-acquired infections.